Person: Joseph Papa

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Bausch & Lomb owner Valeant Pharmaceuticals to cut €28.5bn debt

Valeant Pharmaceuticals, which also owns Bausch & Lomb here, is selling its Dendreon cancer business and three skincare brands for about $2.12bn (€2bn) as the troubled Canadian drugmaker looks to pay down its more than $30bn (€28.5bn) debt.

Wed, 11 Jan, 2017

Perrigo drug firm buyout likley

US-based Mylan yesterday offered to buy fellow drugmaker Perrigo whose headquarters are in Dublin for $28.9bn (€26.73bn), a deal that would create a powerhouse for generic medicine.

Thu, 09 Apr, 2015

€6.5bn takeover of Elan completed

Leading US generic drugmaker Perrigo has formally completed its $8.6bn (€6.5bn) takeover of Irish biotech firm Elan in a cash and share deal.

Fri, 20 Dec, 2013

Person: Joseph Papa

Bausch & Lomb owner Valeant Pharmaceuticals to cut €28.5bn debt

Perrigo drug firm buyout likley

€6.5bn takeover of Elan completed

Latest

Mick Clifford

Person: Joseph Papa

Bausch & Lomb owner Valeant Pharmaceuticals to cut €28.5bn debt

Perrigo drug firm buyout likley

€6.5bn takeover of Elan completed

Latest

Mick Clifford

Most Read